Skip to main content

Platform

AEO Website Research-grade Content Content Factory About Audits Rankings Pricing

Resources

Knowledge Base Research FAQ
Audit
OverviewHow to ImproveScore BreakdownSite PagesGuides
inhibrx.com

inhibrx.com

Weak AI visibility with 24 of 48 criteria passing. Biggest gap: llms.txt file.

Biotech & PharmaceuticalsBiotechnology
47/100
4 since v2
F
Citation Avg
Coherence gate active - score capped at 55
Answer Readiness
~40% weight
5/10
Content Structure
~25% weight
4/10
Trust & Authority
~15% weight
6/10
Technical Foundation
~10% weight
4/10
AI Discovery
~10% weight
5/10

Verdict

Below-average AEO readiness at 47/100 - multiple areas need attention. Key strengths include Internal Linking Structure, Canonical URL Strategy, and Duplicate Content Blocks. Priority gaps: llms.txt File, Q&A Content Format, and Comprehensive FAQ Section. Topic coherence is 4/10, which caps the overall score at 55. Focusing content on core expertise areas is the single highest-impact improvement.

How to Improve

Current
47/100
Projected
79/100
42Total Fixes
13Quick Wins
~87hEst. Effort
Quick Wins
Create /llms.txt fileConfigure robots.txt for AI crawlersImplement semantic HTML5 elementsAdd definition-style contentAdd direct answer paragraphsAdd ai.txt and content licensingEnhance author and expert schemaImprove query-answer alignmentAdd visible date signalsMake pages solve the user task fasterMake content creators clearly visibleImprove citation-ready writing qualityReduce render-blocking resources
Create /llms.txt file
critical|low
Add llms-full.txt with extended content
medium|low
Fix HTML structure and meta tags
medium|low
Reduce render-blocking resources
high|low
Configure robots.txt for AI crawlers
high|trivial
Add internationalization signals
critical|medium
Improve server response efficiency
medium|low
Create complete sitemap.xml
low|low
Reduce document weight
low|low

Top Opportunities10

Ensure blog content consistently covers your core expertise areas rather than scattering across unrelated topics. AI engines build authority models - a site about "Medicare coverage" that also publishes about humidifiers and groceries dilutes its topical authority.

Publish original research, statistics, case studies, or proprietary data that AI engines can cite. Unique data points make your content a primary source rather than a derivative one.

Expand articles to 1000+ words with structured H2/H3 sections, comparison tables, and expert analysis. Thin content (under 300 words) is rarely cited by AI engines. Deep, well-structured articles demonstrate expertise.

Add question-based headings (H2/H3) throughout your content. Use "What is...", "How does...", "Why should..." patterns that match how users query AI assistants.

Use HTML tables for comparison data and ordered/unordered lists for features, steps, and specifications. Structured data formats are directly extractable by AI engines for answers.

Create a dedicated FAQ page with FAQPage schema markup. Cover common questions about your products, services, and industry to become a direct answer source for AI engines.

Write concise, standalone answer paragraphs (2-3 sentences) immediately after question headings. These "snippet-ready" paragraphs are ideal for AI engine citations.

Include "our analysis", "our data", "our testing" phrases backed by original research or proprietary data. 52.2% of AI-cited posts contain owned data signals.

Write 20-25 word self-contained answer sentences immediately after each H2 heading. 72.4% of AI-cited posts use this pattern - it gives engines a ready-made snippet to quote.

Ensure every question-format heading (H2/H3) is followed by a direct answer paragraph. This pattern is ideal for AI engine snippet extraction.

Fix It With AI45

Your competitors are already optimizing for AI

Every day without action is traffic your site loses to AI-ready competitors. We fix that.

Fix My Score

Site Pages

inhibrx.com/teamF33
Our Team | Inhibrx | Meet our experts in biotherapeutics.
inhibrx.com/who-we-areF37
Who We Are | Inhibrx | Fresh perspective. Validated targets.
inhibrx.com/inbrx-106F35
INBRX-106 | Inhibrx | Utilizing a member of the TNFRSF.
inhibrx.com/pipelineF29
Pipeline | Inhibrx | Our targeted immunotherapy candidates.
inhibrx.com/inbrx-106-phase-2-3-trialD43
Phase 2/3 Trial of INBRX-106 + Pembrolizumab in 1L R/M HNSCC - Inhibrx Biosciences
inhibrx.comF36
Inhibrx | Discover our clinical-stage biotechnology company.
inhibrx.com/careersF33
Work with Us - Inhibrx Biosciences Career Opportunities - San Diego, CA
inhibrx.com/inbrx-109-phase-1-trialF39
ozekibart (INBRX-109) Phase 1 Trial - Inhibrx Biosciences
inhibrx.com/contactF36
Contact | Inhibrx | Send us a message.
Changes since v2Last audited 46 days ago
51
47
-4
View full comparison →
Focus Content on Core TopicsAdd Original Data & Case StudiesIncrease Content DepthRestructure Content as Q&AAdd Structured Tables & ListsBuild Comprehensive FAQ SectionAdd Direct Answer ParagraphsAdd Owned Data SignalsAdd Answer Capsule PatternsImprove Question-Answer Alignment

Improve Your Score

Guides for the criteria with the most room for improvement

Related Questions

Browse all FAQs →

Want us to improve your score?

We build citation-ready content that AI engines choose as the answer.

Let's Talk